Erlotinib Recruiting Phase N/A Trials for Malignancies / High-Grade Gliomas Diagnostic

IndicationsStatusPurposePhase
RecruitingDiagnosticNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT02239952HGG-TCP (High Grade Glioma - Tumor Concentrations of Protein Kinase Inhibitors)